
About Nuerepa Biotechnology
Nuerepa Biotechnology is a Healthcare company. Biotechnology company focusing on health management products based on natural principles. The company has 1 employees. Nuerepa Biotechnology offers products and services including Health Queen and H-88. Its focus areas include Medical Devices, Pain Management, Natural Therapy Products and Biotechnology. Its legal entity in India is Nuerepa Biotechnology Private Limited (U51909DL2020FTC374559).
Company details
Nuerepa Biotechnology is identified as a global organization based in South Korea, where research and developments in bio medical and life science fields have been carried out since 2004. It is incorporated as an ISO-certified company with its corporate office located in Delhi, India, under relevant regulations. Products are developed based on natural principles like massage and acupressure, and they are manufactured in Korea using high-quality materials to support health management and wellness. These offerings are designed to address body pain and strengthen human systems, contributing to overall well-being.
- Employees 1
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Social Facebook Instagram YouTube
- Legal Name Nuerepa Biotechnology Private Limited
- Date of Incorporation 15 Dec, 2020
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹73,835
FY 2021
- Indian entity net loss-₹48.7 Lakh
FY 2021 · -6591% margin
- Indian entity EBITDA-₹48.3 Lakh
FY 2021 · -6536% margin
- Employee Count1
Associated legal entities of Nuerepa Biotechnology
Nuerepa Biotechnology operates through Nuerepa Biotechnology Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2021) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nuerepa Biotechnology Private Limited CIN U51909DL2020FTC374559 | Active | 15 Dec 2020 | New Delhi, Delhi | ₹0.0 Cr | 4 | View details |
Products & Services of Nuerepa Biotechnology
Nuerepa Biotechnology offers a comprehensive portfolio of products and services, including Health Queen and H-88.
A device is utilized for ladies' health management through the induction of far infrared rays passing through natural stones.
A spine care massager machine is employed for all age groups and genders to support health management.
Apps and channels of Nuerepa Biotechnology
its YouTube channel Nuerepa Biotechnology has 1.51K subscribers and 28 videos.
Videos from Nuerepa Biotechnology
The most watched videos on Nuerepa Biotechnology's YouTube channel, Nuerepa Biotechnology (1.51K subscribers). Click a video to play it here.
More on Nuerepa Biotechnology.
Board of directors of Nuerepa Biotechnology Private Limited (Nuerepa Biotechnology)
Nuerepa Biotechnology Private Limited is the primary company behind Nuerepa Biotechnology. The board of Nuerepa Biotechnology Private Limited currently have 4 directors; the longest-serving is Hyungjin Shin, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Hyungjin Shin DIN 08997333 | Director | 15 Dec 2020 | 5 yrs 10 mo | Nuerepa Biotechnology Private Limited |
| Sudha Kumari DIN 08997334 | Director | 15 Dec 2020 | 5 yrs 10 mo | Nuerepa Biotechnology Private Limited |
| Young Sik Kim DIN 07505116 | Director | 06 Apr 2022 | 4 yrs 6 mo | Nuerepa Biotechnology Private Limited |
| Dongwon Kim DIN 10176264 | Director | 26 May 2023 | 3 yrs 5 mo | Nuerepa Biotechnology Private Limited |
Financials of Nuerepa Biotechnology
Figures of Nuerepa Biotechnology Private Limited, the primary company behind Nuerepa Biotechnology, for FY 2021. Revenue was ₹73,835. Net loss was -₹48.7 Lakh (-6591% margin). EBITDA was -₹48.3 Lakh (-6536% margin).
- ₹73,835Revenue · FY 2021
- -₹48.7 LakhNet loss · -6591% margin
- -₹48.3 LakhEBITDA · -6536% margin
- ₹1.89 CrPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Nuerepa Biotechnology Private Limited are on its company page.
Detailed financial statements for Nuerepa Biotechnology
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nuerepa Biotechnology
Nuerepa Biotechnology has 1 employees.
The primary company behind Nuerepa Biotechnology, Nuerepa Biotechnology Private Limited, reported revenue of βΉ73,835 for FY 2021.
Nuerepa Biotechnology is identified as a global organization based in South Korea, where research and developments in bio medical and life science fields have been carried out since 2004. It is incorporated as an ISO-certified company with its corporate office located in Delhi, India, under relevant regulations. Products are developed based on natural principles like massage and acupressure, and they are manufactured in Korea using high-quality materials to support health management and wellness. These offerings are designed to address body pain and strengthen human systems, contributing to overall well-being.
Nuerepa Biotechnology offers Health Queen and H-88.
Nuerepa Biotechnology operates through Nuerepa Biotechnology Private Limited.
The legal entities of Nuerepa Biotechnology currently have 4 directors, including Young Sik Kim, Dongwon Kim, Hyungjin Shin and others.